https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.665372/full
Frontiers | Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption...
Background and objectives: Hyzetimibe is a candidate drug as the second-in-class cholesterol absorption inhibitor and lowers plasma levels of LDL-C by blocki...